Homepage
Open in app
Sign in
Get started
de novo
a biotech blog from the Seed Investments group at Novo Holdings
About
Follow
Neuromuscular disease treatments moving in the right direction
Neuromuscular disease treatments moving in the right direction
Skeletal muscles are essential for human movement and account for about 40% of the body mass. They enable various behaviors such as…
João Ribas
Nov 15, 2023
Atrial Fibrillation on the Rise: Challenges and Opportunities for Safer Treatment Options
Atrial Fibrillation on the Rise: Challenges and Opportunities for Safer Treatment Options
Atrial Fibrillation (AF) is the most common type of cardiac arrhythmia, affecting an estimated 4.5 million people in Europe alone.
João Ribas
Sep 27, 2023
Hemab’s Blood Clotting Therapies at the heart of human resilience
Hemab’s Blood Clotting Therapies at the heart of human resilience
While patients with common bleeding and thrombotic disorders have had access to preventative treatments for more than a half-century, no…
João Ribas
May 23, 2023
International Day of Women and Girls in Science — interview with Asgard Therapeutics’ CEO and…
International Day of Women and Girls in Science — interview with Asgard Therapeutics’ CEO and…
Celebrating the International Day of Women and Girls in Science with an interview with Cristiana Pires, co-founder and CEO of Asgard…
João Ribas
Feb 11, 2023
Entrepreneurs in and out of residence — a dual perspective on the role of EiRs in venture creation
Entrepreneurs in and out of residence — a dual perspective on the role of EiRs in venture creation
by Joao Ribas and Martin Bonde
João Ribas
Mar 30, 2022
About de novo
Latest Stories
Archive
About Medium
Terms
Privacy
Teams